IMTX
Price
$5.79
Change
-$0.02 (-0.34%)
Updated
Sep 9, 12:57 PM (EDT)
Capitalization
706.26M
70 days until earnings call
ZVRA
Price
$8.24
Change
-$0.09 (-1.08%)
Updated
Sep 9, 01:28 PM (EDT)
Capitalization
466.76M
57 days until earnings call
Interact to see
Advertisement

IMTX vs ZVRA

Header iconIMTX vs ZVRA Comparison
Open Charts IMTX vs ZVRABanner chart's image
Immatics
Price$5.79
Change-$0.02 (-0.34%)
Volume$300
Capitalization706.26M
Zevra Therapeutics
Price$8.24
Change-$0.09 (-1.08%)
Volume$2.29K
Capitalization466.76M
IMTX vs ZVRA Comparison Chart in %
Loading...
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. ZVRA commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Hold and ZVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (IMTX: $5.81 vs. ZVRA: $8.33)
Brand notoriety: IMTX and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 88% vs. ZVRA: 84%
Market capitalization -- IMTX: $706.26M vs. ZVRA: $466.76M
IMTX [@Biotechnology] is valued at $706.26M. ZVRA’s [@Biotechnology] market capitalization is $466.76M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.34B to $0. The average market capitalization across the [@Biotechnology] industry is $1.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 5 TA indicator(s) are bullish while ZVRA’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 5 bullish, 6 bearish.
  • ZVRA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, both IMTX and ZVRA are a bad buy in the short-term.

Price Growth

IMTX (@Biotechnology) experienced а +14.15% price change this week, while ZVRA (@Biotechnology) price change was -8.16% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.08%. For the same industry, the average monthly price growth was +10.54%, and the average quarterly price growth was +34.85%.

Reported Earning Dates

IMTX is expected to report earnings on Nov 18, 2025.

ZVRA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.08% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($706M) has a higher market cap than ZVRA($467M). ZVRA YTD gains are higher at: -0.120 vs. IMTX (-18.284). ZVRA has higher annual earnings (EBITDA): 36.4M vs. IMTX (-58.05M). IMTX has more cash in the bank: 478M vs. ZVRA (203M). IMTX has less debt than ZVRA: IMTX (17.1M) vs ZVRA (62.3M). IMTX has higher revenues than ZVRA: IMTX (130M) vs ZVRA (62M).
IMTXZVRAIMTX / ZVRA
Capitalization706M467M151%
EBITDA-58.05M36.4M-159%
Gain YTD-18.284-0.12015,249%
P/E Ratio29.35N/A-
Revenue130M62M210%
Total Cash478M203M235%
Total Debt17.1M62.3M27%
FUNDAMENTALS RATINGS
IMTX vs ZVRA: Fundamental Ratings
IMTX
ZVRA
OUTLOOK RATING
1..100
558
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
79
Overvalued
PROFIT vs RISK RATING
1..100
10094
SMR RATING
1..100
9588
PRICE GROWTH RATING
1..100
5762
P/E GROWTH RATING
1..100
5925
SEASONALITY SCORE
1..100
32n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (58) in the null industry is in the same range as ZVRA (79). This means that IMTX’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's Profit vs Risk Rating (94) in the null industry is in the same range as IMTX (100). This means that ZVRA’s stock grew similarly to IMTX’s over the last 12 months.

ZVRA's SMR Rating (88) in the null industry is in the same range as IMTX (95). This means that ZVRA’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's Price Growth Rating (57) in the null industry is in the same range as ZVRA (62). This means that IMTX’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's P/E Growth Rating (25) in the null industry is somewhat better than the same rating for IMTX (59). This means that ZVRA’s stock grew somewhat faster than IMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXZVRA
RSI
ODDS (%)
Bullish Trend 1 day ago
84%
Bullish Trend 1 day ago
89%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
79%
Bearish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
79%
Bearish Trend 1 day ago
77%
Advances
ODDS (%)
Bullish Trend 5 days ago
78%
Bullish Trend 5 days ago
81%
Declines
ODDS (%)
Bearish Trend 12 days ago
79%
Bearish Trend 12 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
85%
Bullish Trend 1 day ago
83%
Aroon
ODDS (%)
Bearish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
BGSAX71.371.28
+1.83%
BlackRock Technology Opportunities Inv A
TMDIX19.440.23
+1.20%
AMG TimesSquare Mid Cap Growth Z
LSOFX18.78N/A
N/A
LS Opportunity Fund Institutional Class
ENPIX39.43-0.14
-0.35%
ProFunds UltraSector Energy Investor
JCVCX24.72-0.10
-0.40%
JHancock Classic Value C

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with CRNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
-7.19%
CRNX - IMTX
49%
Loosely correlated
-1.32%
OCUL - IMTX
49%
Loosely correlated
-6.54%
IDYA - IMTX
49%
Loosely correlated
-13.88%
CGON - IMTX
48%
Loosely correlated
+1.87%
DAWN - IMTX
47%
Loosely correlated
-1.06%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with IMTX. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then IMTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
-6.93%
IMTX - ZVRA
34%
Loosely correlated
-7.19%
RIGL - ZVRA
34%
Loosely correlated
-1.14%
OCUL - ZVRA
34%
Loosely correlated
-6.54%
ETNB - ZVRA
33%
Poorly correlated
-3.38%
EYPT - ZVRA
33%
Poorly correlated
-2.57%
More